NNVC
NanoViricides (NNVC)
$49
About NanoViricides (NNVC)
NanoViricides, Inc. is a clinical stage company, which engages in the development of nanomedicine drugs against viruses. It focuses on anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs. The company was founded by Anil R. Diwan on April 1, 2005 and is headquartered in Shelton, CT.
Details
Daily high
$1.53
Daily low
$1.42
Price at open
$1.43
52 Week High
$3.59
52 Week Low
$1.00
Market cap
21.4M
Dividend yield
0.00%
Volume
547,885
Avg. volume
246,356
P/E ratio
-1.96
NanoViricides News
Details
Daily high
$1.53
Daily low
$1.42
Price at open
$1.43
52 Week High
$3.59
52 Week Low
$1.00
Market cap
21.4M
Dividend yield
0.00%
Volume
547,885
Avg. volume
246,356
P/E ratio
-1.96